Danielle Nance, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    CSL Behring
    Topic:
    Gene therapy Hemophilia B
    Date added:
    01/01/2024
    Date updated:
    01/06/2025
    Relationship end date:
    12/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Promacta and ITP
    Date added:
    01/01/2024
    Date updated:
    01/06/2025
    Relationship end date:
    03/16/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Biomarin
    Topic:
    Gene therapy Hemophilia A
    Date added:
    01/01/2024
    Date updated:
    01/06/2025
    Relationship end date:
    07/15/2023
Return to Best of Hematology and Breast Cancer 2025, Phoenix